PHARMAC takes significant step towards national hospital medicines list New Zealand Doctor Online One of the changes has been the addition of rituximab (Mabthera) to the rheumatology list. Rituximab, a targeted biologic medicine, had already been available as a treatment for some forms of leukaemia and lymphoma but only some DHBs were using it for ... |
